E R Kurniawati1, V G H Rutjens2, N P A Vranken2, T S R Delnoij3,4, R Lorusso2,5, I C C van der Horst3,5, J G Maessen2,5, P W Weerwind2,5. 1. Department of Cardiothoracic Surgery, Maastricht University Medical Center+, P. Debyelaan 25, PO Box 5800, 6202 AZ, Maastricht, the Netherlands. eva.kurniawati@mumc.nl. 2. Department of Cardiothoracic Surgery, Maastricht University Medical Center+, P. Debyelaan 25, PO Box 5800, 6202 AZ, Maastricht, the Netherlands. 3. Department of Intensive Care Medicine, Maastricht University Medical Center+, Maastricht, the Netherlands. 4. Department of Cardiology, Maastricht University Medical Center+, Maastricht, the Netherlands. 5. Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, the Netherlands.
Abstract
BACKGROUND: Veno-venous extracorporeal membrane oxygenation (VV-ECMO) has been used successfully for the past decade in adult patients with acute respiratory distress syndrome (ARDS) refractory to conventional ventilatory support. However, knowledge of the health-related quality of life (HRQoL) in VV-ECMO patients is still limited. Thus, this study aimed to provide a comprehensive overview of the HRQoL following VV-ECMO support in ARDS patients. METHODS: A systematic search was performed on PubMed and Web of Science databases from January 1st, 2009 to October 19th, 2020. Studies reporting on HRQoL following VV-ECMO for ARDS in adults were included. Two authors independently selected studies, extracted data, and assessed methodological quality. RESULTS: Eight studies were eligible for inclusion, consisting of seven observational studies and one randomized controlled trial (total N = 441). All eight studies had a quantitative design and reported 265 VV-ECMO survivors to have a reduced HRQoL compared to a generally healthy population. Follow-up time varied between six months to three years. Additionally, only four studies (total N = 335) compared the HRQoL of VV-ECMO (N = 159) to conventionally treated survivors (N = 176), with one study showing a significantly better HRQoL in VV-ECMO survivors, while three studies were stating comparable HRQoL across groups. Notably, most survivors in these studies appeared to experience varying degrees of anxiety, depression, and post-traumatic stress disorder (PTSD). CONCLUSIONS: ARDS survivors supported by VV-ECMO have a decline in HRQoL and suffered from physical and psychological impairments. This HRQoL reduction is comparable or even better to the HRQoL in conventionally treated ARDS survivors.
BACKGROUND: Veno-venous extracorporeal membrane oxygenation (VV-ECMO) has been used successfully for the past decade in adult patients with acute respiratory distress syndrome (ARDS) refractory to conventional ventilatory support. However, knowledge of the health-related quality of life (HRQoL) in VV-ECMO patients is still limited. Thus, this study aimed to provide a comprehensive overview of the HRQoL following VV-ECMO support in ARDSpatients. METHODS: A systematic search was performed on PubMed and Web of Science databases from January 1st, 2009 to October 19th, 2020. Studies reporting on HRQoL following VV-ECMO for ARDS in adults were included. Two authors independently selected studies, extracted data, and assessed methodological quality. RESULTS: Eight studies were eligible for inclusion, consisting of seven observational studies and one randomized controlled trial (total N = 441). All eight studies had a quantitative design and reported 265 VV-ECMO survivors to have a reduced HRQoL compared to a generally healthy population. Follow-up time varied between six months to three years. Additionally, only four studies (total N = 335) compared the HRQoL of VV-ECMO (N = 159) to conventionally treated survivors (N = 176), with one study showing a significantly better HRQoL in VV-ECMO survivors, while three studies were stating comparable HRQoL across groups. Notably, most survivors in these studies appeared to experience varying degrees of anxiety, depression, and post-traumatic stress disorder (PTSD). CONCLUSIONS:ARDS survivors supported by VV-ECMO have a decline in HRQoL and suffered from physical and psychological impairments. This HRQoL reduction is comparable or even better to the HRQoL in conventionally treated ARDS survivors.
Entities:
Keywords:
Acute respiratory distress syndrome; Adult; Health-related quality of life; Veno-venous extracorporeal life support; Veno-venous extracorporeal membrane oxygenation
Authors: Giacomo Bellani; John G Laffey; Tài Pham; Eddy Fan; Laurent Brochard; Andres Esteban; Luciano Gattinoni; Frank van Haren; Anders Larsson; Daniel F McAuley; Marco Ranieri; Gordon Rubenfeld; B Taylor Thompson; Hermann Wrigge; Arthur S Slutsky; Antonio Pesenti Journal: JAMA Date: 2016-02-23 Impact factor: 56.272
Authors: Asif K Mustafa; Philip J Alexander; Devang J Joshi; Deborah R Tabachnick; Chadrick A Cross; Pat S Pappas; Antone J Tatooles Journal: JAMA Surg Date: 2020-08-11 Impact factor: 14.766
Authors: Ayan Sen; Hannelisa E Callisen; Cory M Alwardt; Joel S Larson; Amelia A Lowell; Stacy L Libricz; Pritee Tarwade; Bhavesh M Patel; Harish Ramakrishna Journal: Ann Card Anaesth Date: 2016 Jan-Mar
Authors: Pierre-Emmanuel Falcoz; Alexandra Monnier; Marc Puyraveau; Stephanie Perrier; Pierre-Olivier Ludes; Anne Olland; Paul-Michel Mertes; Francis Schneider; Julie Helms; Ferhat Meziani Journal: Am J Respir Crit Care Med Date: 2020-08-01 Impact factor: 21.405
Authors: Mario Menk; Elisa Estenssoro; Sarina K Sahetya; Ary Serpa Neto; Pratik Sinha; Arthur S Slutsky; Charlotte Summers; Takeshi Yoshida; Thomas Bein; Niall D Ferguson Journal: Intensive Care Med Date: 2020-11-06 Impact factor: 17.440
Authors: Venkatakrishna Rajajee; Christopher Mon-Chee Fung; Katharine Surella Seagly; Pauline Kyonsook Park; Krishnan Raghavendran; David Antonio Machado-Aranda; Jonathan William Scott; Matthew Joseph Delano; Ashraf Shaaban Abdel Aziz Abou El Ela; Jonathan William Haft; Craig Andrew Williamson; Jakob Israel McSparron; Ross Blank; Lena Marie Napolitano Journal: Crit Care Explor Date: 2021-09-10